Meritain Eldorado policies, page 100

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Eldorado, by title.

Meritain Eldorado policies
PolicyDetailsCodesSource
Intestinal Transplantation0605 · Commercial28Original policy ↗
Intradiscal Procedures0602 · Commercial21Original policy ↗
Intragastric Hypothermia0527 · Commercial1Original policy ↗
Intranasal Ablation0592 · Commercial6Original policy ↗
Intraoperative Neurophysiological Monitoring0697 · Commercial307Original policy ↗
Intravascular Optical Coherence Tomography0829 · Commercial22Original policy ↗
Intravascular Ultrasound0382 · Commercial52Original policy ↗
Intravenous Iron Therapy0575 · Commercial28Original policy ↗
Invasive Prenatal Diagnosis of Genetic Diseases0358 · Commercial39Original policy ↗
Isturisa 3667-A SGM P20213667-A · Commercial—Original policy ↗
Isturisa 3667-A SGM P20213667-A · Commercial—Original policy ↗
Isturisa 3667-A SGM P20213667-A · Commercial—Original policy ↗
Isturisa 3667-A SGM P20213667-A · Commercial—Original policy ↗
Isturisa 3667-A SGM P20213667-A · Commercial—Original policy ↗
Itraconazole (Sporanox Oral Solution) PA 210-A P03-2026210-A P03-2026 · Commercial—Original policy ↗
Itraconazole (Sporanox Oral Solution) PA 4523-A P03-20264523-A · Commercial—Original policy ↗
IVIG 2042-A SGM P2023a2042-A · Commercial—Original policy ↗
Iwilfin 6294-A SGM P20236294-A · Commercial—Original policy ↗
Iwilfin SGM 6294-A P2024_R6294-A · Commercial—Original policy ↗
Ixabepilone (Ixempra)0869 · Commercial22Original policy ↗
Jaw Motion Rehabilitation Systems0412 · Commercial7Original policy ↗
Jetrea 3000-A SGM P2021P2021 · Commercial—Original policy ↗
Jetrea 3000-A SGM P2021P2021 · Commercial—Original policy ↗
Joint Resurfacing0661 · Commercial11Original policy ↗
Jublia PA with Limit 1160-C P10-20251160-C · Commercial—Original policy ↗
Kanuma 2094-A SGM P20212094-A · Commercial—Original policy ↗
Karbinal ER ST, Post PA (Aetna FI ACF, Aetna FI ACFC Only) 2928-D P02-20262928-D · Commercial—Original policy ↗
Kesimpta 4129-A SGM P20234129-A · Commercial—Original policy ↗
Ketorolac Limit 233-H P10-2024_R233-H P10-2024_R · Commercial—Original policy ↗
Keveyis 2491-A SGM P20232491-A · Commercial—Original policy ↗
Keveyis 2491-A SGM P20232491-A · Commercial—Original policy ↗
Kevzara 1957-A SGM P2022a1957-A · Commercial—Original policy ↗
Kidney Stones: Selected Interventions0392 · Commercial17Original policy ↗
Kidney Transplantation0493 · Commercial68Original policy ↗
Kloxxado, Narcan, Zimhi Limit Policy 1137-H 02-20231137-H · Commercial—Original policy ↗
Knee Arthroplasty0660 · Commercial31Original policy ↗
Knee Ligament Arthrometer Testing0397 · Commercial10Original policy ↗
Korlym 2160-A SGM P20212160-A · Commercial—Original policy ↗
Kuvan 2012-A SGM P20212012-A SGM P2021 · Commercial—Original policy ↗
Laboratory Tests for Depression and Other Psychiatric Disorders0306 · Commercial14Original policy ↗
Laser Neurolysis0552 · Commercial9Original policy ↗
Laser Photocoagulation of Drusen0609 · Commercial1Original policy ↗
Laser Treatment for Psoriasis and Other Selected Skin Conditions0577 · Commercial17Original policy ↗
Lead Testing0553 · Commercial1Original policy ↗
lenalidomide-Revlimid SGM 2232-A P20242232-A · Commercial—Original policy ↗
Leukine 1929-A SGM P20211929-A · Commercial—Original policy ↗
Levulan Kerastick Limit, Post PA Policy 2934-HJ UDR 04-20232934-HJ · Commercial—Original policy ↗
Lidocaine, Combinations Topical Limit 1329-H P10-2024_R1329-H · Commercial—Original policy ↗
Linzess PA Policy 843-A, 1023-A UDR 10-2023843-A, 1023-A · Commercial—Original policy ↗
Liver and Other Neoplasms - Treatment Approaches0268 · Commercial29Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.